Caption Management’s GSK GSK Stock Holding History

Caption Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-20,000	Closed	-$770K	–	1411
2024 Q2	$770K	Buy	+20,000	New	+$841K	0.01%	723

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Caption Management's GSK Position: Q3 2023 in Review

Caption Management sold out of GSK (GSK) in Q3 2023, closing a stake of 100 shares — an estimated $3.55K sold.

Caption Management first reported a position in GSK in Q4 2022 and held it in 2 quarters. The position peaked at $2.71M in Q4 2022. 846 funds tracked by Wall St. Rank hold GSK as of Q3 2023.

Caption Management reported no remaining GSK position as of Q3 2023 after selling out during the quarter.
Caption Management sold 100 GSK shares in Q3 2023, an estimated $3.55K.
Caption Management first reported a position in GSK in Q4 2022 and held it in 2 quarters.
Caption Management's GSK position peaked at $2.71M in Q4 2022.
846 funds tracked by Wall St. Rank held GSK as of Q3 2023.

Based on Caption Management's 13F filing for Q3 2023, filed 14 Nov 2023.